Primary biliary cirrhosis is characterized by the presence of autoantibodies to mitochondria with specific reactivity to proteins of 74 and 52 kilodaltons (kd). The 74-kd mitochondrial protein is the E2 component--dihydrolipoamide acetyltransferase--of the pyruvate dehydrogenase complex, and the 52-kd protein is the equivalent E2 component--dihydrolipoamide acyltransferase--of the branched-chain alpha-keto acid dehydrogenase complex. Current methods for the detection of antibodies to these proteins lack specificity or sensitivity, or they are time-consuming and not readily available. We therefore developed an enzyme-linked immunoassay to quantify specific antimitochondrial antibodies in patients with primary biliary cirrhosis. Recombinant polypeptides coding for both the 74-kd and the 52-kd mitochondrial autoantigens were used to analyze 217 coded serum samples, including samples from 93 patients with primary biliary cirrhosis and 124 controls, for reactivity by our immunoassay, immunoblotting, and immunofluorescence testing. Serum samples from 89 of the 93 patients with primary biliary cirrhosis reacted with either the pyruvate dehydrogenase-E2 or the branched-chain alpha-keto acid dehydrogenase protein. None of the 124 control samples from healthy volunteers (n = 86) or patients with primary sclerosing cholangitis (n = 38) had significant reactivity. Our results indicate that the use of recombinant, cloned autoantigens provides a simple, accurate, and rapid method of quantifying and monitoring the levels of specific mitochondrial autoantibodies in the serum of patients with primary biliary cirrhosis.
Source Information
Division of Rheumatology/Allergy and Clinical Immunology, University of California, Davis 95616.
This article has been cited by other articles:
ASSASSI, S., FRITZLER, M. J., ARNETT, F. C., NORMAN, G. L., SHAH, K. R., GOURH, P., MANEK, N., PERRY, M., GANESH, D., RAHBAR, M. H., MAYES, M. D.
(2009). Primary Biliary Cirrhosis (PBC), PBC Autoantibodies, and Hepatic Parameter Abnormalities in a Large Population of Systemic Sclerosis Patients. The Journal of Rheumatology
36: 2250-2256
[Abstract][Full Text]
Dahnrich, C., Pares, A., Caballeria, L., Rosemann, A., Schlumberger, W., Probst, C., Mytilinaiou, M., Bogdanos, D., Vergani, D., Stocker, W., Komorowski, L.
(2009). New ELISA for Detecting Primary Biliary Cirrhosis-Specific Antimitochondrial Antibodies. Clin. Chem.
55: 978-985
[Abstract][Full Text]
Kim, K., Lerou, P., Yabuuchi, A., Lengerke, C., Ng, K., West, J., Kirby, A., Daly, M. J., Daley, G. Q.
(2007). Histocompatible Embryonic Stem Cells by Parthenogenesis. Science
315: 482-486
[Abstract][Full Text]
Koarada, S., Wu, Y., Fertig, N., Sass, D. A., Nalesnik, M., Todd, J. A., Lyons, P. A., Fenyk-Melody, J., Rainbow, D. B., Wicker, L. S., Peterson, L. B., Ridgway, W. M.
(2004). Genetic Control of Autoimmunity: Protection from Diabetes, but Spontaneous Autoimmune Biliary Disease in a Nonobese Diabetic Congenic Strain. J. Immunol.
173: 2315-2323
[Abstract][Full Text]
Blachar, A., Federle, M. P., Brancatelli, G.
(2001). Primary Biliary Cirrhosis: Clinical, Pathologic, and Helical CT Findings in 53 Patients. Radiology
220: 329-336
[Abstract][Full Text]
Schmit, P., Gilson, G., Humbel, R. L.
(1999). Evaluation of an Automated Enzyme Inhibition Assay for the Detection of Anti-Mitochondrial M2 Autoantibodies. Clin. Chem.
45: 2287-2289
[Full Text]
Melegh, B, Skuta, G, Pajor, L, Sumegi, B
(1998). Autoantibodies against subunits of pyruvate dehydrogenase and citrate synthase in a case of paediatric biliary cirrhosis. Gut
42: 753-756
[Abstract][Full Text]
Worman, H. J.
(1997). Molecular biological methods in diagnosis and treatment of liver diseases. Clin. Chem.
43: 1476-1486
[Abstract][Full Text]
Kaplan, M. M.
(1996). Primary Biliary Cirrhosis. NEJM
335: 1570-1580
[Full Text]
Czaja, A. J.
(1996). The Variant Forms of Autoimmune Hepatitis. ANN INTERN MED
125: 588-598
[Abstract][Full Text]